Bresnahan Votes to Prevent Dangerous Fentanyl Trafficking
WASHINGTON, DC: Today, U.S. Representative Rob Bresnahan, Jr. (PA-08) voted in favor of H.R. 27, the Halt All Lethal Trafficking (HALT) Fentanyl Act. This bipartisan legislation, which passed the House by a vote of 312-108, would remove incentives for the creation of new, dangerous substances by permanently designating fentanyl analogues in schedule 1 of the Controlled Substances Act (CSA).
“As someone who has lost a family member to the fentanyl crisis, I know that no community is immune from this epidemic,” said Rep. Bresnahan. “We could not afford to sit idly by, and I am proud we took this significant action. The HALT Fentanyl Act confronts this crisis head on, protecting our children, families, and neighbors from this dangerous substance.”
One Pennsylvanian dies from a drug overdose every two hours. Rep. Bresnahan’s cousin lost her life to the fentanyl crisis when she was only 16 years old. In 2023, 76% of overdose-related deaths in Pennsylvania involve fentanyl.
Rep. Bresnahan spoke in favor of the legislation on the House Floor today. Yesterday, he addressed the fentanyl crisis during a hearing of the House Committee on Small Business.
The HALT Fentanyl Act would permanently classify fentanyl analogues, which are fentanyl-related substances, as Schedule I drugs, which are substances with a high potential for abuse and no accepted medical use. Schedule I designation for fentanyl analogues currently operates on a temporary basis and is set to expire at the end of next month.
You can read the full bill here.
###